Back to Search
Start Over
Increased Risk of Pyogenic Liver Abscess after Endoscopic Sphincterotomy for Treatment of Choledocholithiasis.
- Source :
-
Infection and drug resistance [Infect Drug Resist] 2021 Jun 08; Vol. 14, pp. 2121-2131. Date of Electronic Publication: 2021 Jun 08 (Print Publication: 2021). - Publication Year :
- 2021
-
Abstract
- Background and Aim: Endoscopic sphincterotomy (ES) abolished the barrier between the hepatobiliary system and duodenum and might be at risk of pyogenic liver abscess (PLA). We aimed to identify the association factors of PLA in patients who underwent endoscopic retrograde cholangiopancreatography (ERCP) procedures for treatment of choledocholithiasis.<br />Methods: This study was based on the Chung Gung Research Database (CGRD) between January 1, 2001 and December 31, 2018. Those who had an International Classification of Diseases, Ninth and Tenth Revision (ICD9 and ICD10) codes of choledocholithiasis and received ERCP were enrolled. After strict exclusions, 11,697 patients were further divided into the endoscopic sphincterotomy (ES) group (n=7,111) and other ERCP group (n=4,586) for analysis.<br />Results: Patients receiving ES had significantly higher rates of PLA than those of the other ERCP group (5-year cumulative incidence 2.4% versus 1.7%; 10-year cumulative incidence 3.9% versus 3.2%, log-rank p =0.0177). Aging, male gender, surgery for hepato-pancreato-biliary system and hepatobiliary malignancy were significant association factors of PLA. On multivariate analysis, the ES increased the risk of PLA (adjusted hazard ratio [aHR]=1.49; 95% CI=1.12-1.98; p =0.0058) but decreased the risks for acute pancreatitis (aHR=0.72; 95% CI=0.60-0.85; p =0.0002) and cholangitis (aHR= 0.91; 95% CI=0.84-0.99; p =0.0259). There was no significant difference about recurrent choledocholithiasis between groups.<br />Conclusion: This study demonstrated a significant risk of PLA after patients receiving ES compared with the other ERCP group. We should also carefully monitor the association factors of PLA after ERCP treatment of choledocholithiasis including aging, male gender, surgery for the hepato-pancreato-biliary system and hepatobiliary malignancy.<br />Competing Interests: The authors declared that they have no conflicts of interest.<br /> (© 2021 Wu et al.)
Details
- Language :
- English
- ISSN :
- 1178-6973
- Volume :
- 14
- Database :
- MEDLINE
- Journal :
- Infection and drug resistance
- Publication Type :
- Academic Journal
- Accession number :
- 34135602
- Full Text :
- https://doi.org/10.2147/IDR.S312545